mirtazapine has been researched along with Benign Essential Tremor in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)." | 9.10 | Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003) |
| "We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)." | 5.10 | Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pahwa, R | 1 |
| Lyons, KE | 1 |
1 trial available for mirtazapine and Benign Essential Tremor
| Article | Year |
|---|---|
Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
Topics: Aged; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Essential Tremor; F | 2003 |